Your browser doesn't support javascript.
loading
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma.
Wang, Michael; Rule, Simon; Zinzani, Pier Luigi; Goy, Andre; Casasnovas, Olivier; Smith, Stephen D; Damaj, Gandhi; Doorduijn, Jeanette K; Lamy, Thierry; Morschhauser, Franck; Panizo, Carlos; Shah, Bijal; Davies, Andrew; Eek, Richard; Dupuis, Jehan; Jacobsen, Eric; Kater, Arnon P; Le Gouill, Steven; Oberic, Lucie; Robak, Tadeusz; Jain, Preetesh; Frigault, Melanie M; Izumi, Raquel; Nguyen, Dorothy; Patel, Priti; Yin, Ming; Dlugosz-Danecka, Monika.
Afiliação
  • Wang M; MD Anderson Cancer Center, University of Texas, Houston, TX, USA. miwang@mdanderson.org.
  • Rule S; Plymouth University Medical School, Plymouth, UK.
  • Zinzani PL; Institute of Hematology "Seràgnoli", University of Bologna, Bologna, Italy.
  • Goy A; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
  • Casasnovas O; CHU Dijon - Hôpital d'Enfants, Dijon, France.
  • Smith SD; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA.
  • Damaj G; Institut d'Hématologie de Basse-Normandie, Caen, France.
  • Doorduijn JK; Erasmus MC, HOVON Lunenburg Lymphoma Phase I/II Consortium, Rotterdam, Netherlands.
  • Lamy T; CHU de Rennes, Rennes, France.
  • Morschhauser F; Univ. Lille, CHU Lille, EA 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, F-59000, Lille, France.
  • Panizo C; Clínica Universidad de Navarra, Pamplona, Spain.
  • Shah B; Moffitt Cancer Center, Tampa, FL, USA.
  • Davies A; Cancer Research UK Centre, University of Southampton Faculty of Medicine, Southampton, UK.
  • Eek R; Border Medical Oncology, Albury, Victoria, Australia.
  • Dupuis J; Unité Hémopathies Lymphoïdes, AP-HP Hôpital Henri Mondor, Créteil, France.
  • Jacobsen E; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Kater AP; Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, HOVON Lunenburg Lymphoma Phase I/II Consortium, Amsterdam, Netherlands.
  • Le Gouill S; CHU de Nantes-Hotel Dieu, Nantes, France.
  • Oberic L; Institut Universitaire du Cancer-Oncopole Toulouse (IUCT-O), Toulouse, France.
  • Robak T; Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland.
  • Jain P; MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
  • Frigault MM; Acerta Pharma, South San Francisco, CA, USA.
  • Izumi R; Acerta Pharma, South San Francisco, CA, USA.
  • Nguyen D; Acerta Pharma, South San Francisco, CA, USA.
  • Patel P; Acerta Pharma, South San Francisco, CA, USA.
  • Yin M; Acerta Pharma, South San Francisco, CA, USA.
  • Dlugosz-Danecka M; Department of Haematology, Jagiellonian University, Krakow, Poland.
Leukemia ; 33(11): 2762-2766, 2019 11.
Article em En | MEDLINE | ID: mdl-31558766
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinas / Benzamidas / Resistencia a Medicamentos Antineoplásicos / Linfoma de Célula do Manto / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinas / Benzamidas / Resistencia a Medicamentos Antineoplásicos / Linfoma de Célula do Manto / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos